Day J, Hamann P
Diagnostics (Basel). 2025; 14(24.
PMID: 39767202
PMC: 11675675.
DOI: 10.3390/diagnostics14242842.
van Wijck R, Sharma H, Swagemakers S, Dik W, IJspeert H, Dalm V
Front Med (Lausanne). 2024; 11:1381031.
PMID: 38938383
PMC: 11208482.
DOI: 10.3389/fmed.2024.1381031.
Nelson N, Kogan R, Condos R, Hena K
J Clin Med. 2024; 13(1).
PMID: 38202021
PMC: 10779381.
DOI: 10.3390/jcm13010015.
Hwang E, Abdelghaffar M, Shields B, Damsky W
JID Innov. 2023; 3(5):100220.
PMID: 37719661
PMC: 10500476.
DOI: 10.1016/j.xjidi.2023.100220.
Sambon P, Sellimi A, Kozyreff A, Gheysens O, Pothen L, Yildiz H
Front Neurol. 2022; 13:970168.
PMID: 36388212
PMC: 9641157.
DOI: 10.3389/fneur.2022.970168.
The Evolving Landscape of Cutaneous Sarcoidosis: Pathogenic Insight, Clinical Challenges, and New Frontiers in Therapy.
Wu J, Imadojemu S, Caplan A
Am J Clin Dermatol. 2022; 23(4):499-514.
PMID: 35583850
DOI: 10.1007/s40257-022-00693-0.
The CSF in neurosarcoidosis contains consistent clonal expansion of CD8 T cells, but not CD4 T cells.
Paley M, Baker B, Dunham S, Linskey N, Cantoni C, Lee K
J Neuroimmunol. 2022; 367:577860.
PMID: 35405431
PMC: 9338453.
DOI: 10.1016/j.jneuroim.2022.577860.
Treatment of cutaneous sarcoidosis with tofacitinib: A case report and review of evidence for Janus kinase inhibition in sarcoidosis.
Talty R, Damsky W, King B
JAAD Case Rep. 2021; 16:62-64.
PMID: 34522749
PMC: 8427262.
DOI: 10.1016/j.jdcr.2021.08.012.
Successful treatment of ulcerated pyoderma gangrenosum with baricitinib, a novel JAK inhibitor.
Scheinberg M, Machado L, M Castro L, Berbert Ferreira S, Michalany N
J Transl Autoimmun. 2021; 4:100099.
PMID: 33997753
PMC: 8100614.
DOI: 10.1016/j.jtauto.2021.100099.
Tofacitinib as a Steroid-Sparing Therapy in Pulmonary Sarcoidosis, an Open-Label Prospective Proof-of-Concept Study.
Friedman M, Le B, Stevens J, Desmarais J, Seifer D, Ogle K
Lung. 2021; 199(2):147-153.
PMID: 33825964
PMC: 8092019.
DOI: 10.1007/s00408-021-00436-8.
Emerging Molecular Targets for the Treatment of Refractory Sarcoidosis.
Boleto G, Vieira M, Desbois A, Saadoun D, Cacoub P
Front Med (Lausanne). 2020; 7:594133.
PMID: 33330556
PMC: 7732552.
DOI: 10.3389/fmed.2020.594133.
